CBD-rich cannabis extract dramatically increased a "probiotic" gut bacterium in mice but also triggered intestinal inflammation | Research

The takeaway

In mice, a CBD-rich cannabis extract dramatically increased Akkermansia muciniphila (a bacterium considered probiotic) while simultaneously triggering pro-inflammatory responses and decreasing gut integrity markers.

Gastroenterologists, microbiome researchers, and CBD consumers with gut health concerns.

CBD increased "probiotic" A. muciniphila but also triggered gut inflammation

What the researchers found

CBD-rich cannabis extract (CRCE) at multiple doses substantially increased the gut bacterium Akkermansia muciniphila (currently considered probiotic) in mouse fecal samples. However, this was accompanied by increased pro-inflammatory cytokines and chemokines (IL-1β, CXCL1, CXCL2) in colon tissue, and the increased A. muciniphila significantly decreased expression of Muc2, a gene critical for gut integrity.

Why it matters

CBD products are marketed for gut health, but this study shows a paradox: CBD increased a "beneficial" bacterium while simultaneously triggering inflammation. This challenges simplistic narratives about CBD gut effects and raises safety concerns about long-term use.

The numbers in context

All CRCE doses increased A. muciniphila; IL-1β, CXCL1, CXCL2 increased in colon; Muc2 expression decreased; effects at doses from 61.5 to 615 mg/kg/day.

How the study worked

Male C57BL/6J mice gavaged with CRCE (0, 61.5, 184.5, or 615 mg/kg/day) for 2 weeks. Gut microbiome analyzed by 16S sequencing; colonic gene expression measured by qPCR; histomorphological analysis of gut mucosa.

What this study cannot tell us

Mouse model (gut microbiome differs from humans); CBD-rich extract (not pure CBD; contains other cannabinoids); high doses relative to human use; 2-week duration; male mice only; inflammatory markers do not necessarily indicate clinical disease.

How to read the evidence

Preliminary: novel and concerning finding, but mouse model with high doses and CBD-rich extract rather than pure CBD.

When this study was published

Published 2020.

The bigger picture

The gut is emerging as a key site of cannabinoid action. This study demonstrates that "good" microbiome changes (more A. muciniphila) can coexist with harmful tissue effects (inflammation, reduced mucus integrity). Microbiome composition alone does not predict gut health.

Questions still open

Would pure CBD have the same paradoxical gut effects? Are these inflammatory changes clinically relevant at human-equivalent doses?

Common questions

Is CBD good for gut health?

It may be more complicated than assumed. This study found CBD-rich extract increased a bacterium considered beneficial while simultaneously triggering intestinal inflammation and reducing gut integrity. This paradox warrants caution about long-term CBD use for gut health.

What was the concerning finding?

While A. muciniphila (considered probiotic) dramatically increased, pro-inflammatory markers (IL-1β, CXCL1, CXCL2) also increased in the colon, and the gene for gut-protective mucus (Muc2) decreased. Good bacteria and bad inflammation can coexist.

Read the original research

Potential Probiotic or Trigger of Gut Inflammation - The Janus-Faced Nature of Cannabidiol-Rich Cannabis Extract.

Journal of dietary supplements, 17(5), 543-560

View on PubMed ↗Publisher’s paper ↗

Citation

Skinner, Charles M; Nookaew, Intawat; Ewing, Laura E; Wongsurawat, Thidathip; Jenjaroenpun, Piroon; Quick, Charles M; Yee, Eric U; Piccolo, Brian D; ElSohly, Mahmoud; Walker, Larry A; Gurley, Bill; Koturbash, Igor. (2020). Potential Probiotic or Trigger of Gut Inflammation - The Janus-Faced Nature of Cannabidiol-Rich Cannabis Extract.. Journal of dietary supplements, 17(5), 543-560. https://doi.org/10.1080/19390211.2020.1761506